RankingsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Long-term debt, non-current

ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】

Market cap
¥608.6B
P/E ratio
18.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndLong-term debt, non-current (Million JPY)YoY (%)
Mar 31, 202517,818+243.31%
Mar 31, 20245,190-30.95%
Mar 31, 20237,516-43.70%
Mar 31, 202213,350+130.69%
Mar 31, 20215,787+11.50%
Mar 31, 20205,190+264.47%
Mar 31, 20191,424-16.33%
Mar 31, 20181,702-3.57%
Mar 31, 20171,765+77.57%
Mar 31, 2016994-7.45%
Mar 31, 20151,074

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)